What is the proper dosage and usage of Ivermectin for parasitic infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ivermectin Dosage and Usage for Parasitic Infections

For standard parasitic infections, ivermectin should be administered at 200 μg/kg orally as a single dose, with a second dose given 14 days after the first dose to ensure complete treatment. 1

Standard Dosing Regimens

Common Parasitic Infections (e.g., Scabies)

  • Dose: 200 μg/kg orally
  • Administration: Single dose, repeated in 2 weeks
  • Administration tips: Take with food to increase bioavailability and drug penetration into the epidermis 1
  • No dosage adjustment needed: For patients with renal impairment 1
  • Caution: Safety of multiple doses in severe liver disease is not established 1

Crusted Scabies (Norwegian Scabies)

For immunodeficient, debilitated, or malnourished patients with crusted scabies, a more intensive regimen is required:

  • Combination therapy recommended: Oral ivermectin plus topical scabicide
  • Oral ivermectin: 200 μg/kg on days 1,2,8,9, and 15
  • Additional doses: May require treatment on days 22 and 29 for severe cases 1
  • Topical component: Either 5% topical benzyl benzoate or 5% topical permethrin cream (full-body application daily for 7 days, then twice weekly until cure) 1

Special Populations

Pregnancy

  • Ivermectin is classified as "human data suggest low risk" in pregnancy and probably compatible with breastfeeding 1
  • No teratogenicity or toxicity attributable to ivermectin has been observed in human pregnancy 1

Children

  • Infants and young children should preferably be treated with permethrin rather than ivermectin 1

HIV-Infected Patients

  • Same treatment regimen as HIV-negative individuals 1

Important Clinical Considerations

Treatment Efficacy

  • Ivermectin has limited ovicidal activity and may not prevent recurrences from eggs present at the time of treatment, which is why a second dose after 14 days is crucial 1

Management of Treatment Failure

  • Symptoms persisting >2 weeks after treatment may indicate:
    • Resistance to medication
    • Faulty application
    • Reinfection from untreated contacts
    • Cross-reactivity with other mites
    • Allergic dermatitis 1
  • If symptoms persist or live mites are observed after treatment, consider retreatment or alternative regimen 1

Environmental Management

  • Decontaminate bedding and clothing (machine wash/dry using hot cycle or dry clean)
  • Alternatively, remove items from body contact for at least 72 hours
  • Keep fingernails closely trimmed to reduce injury from scratching 1

Common Pitfalls to Avoid

  1. Failure to repeat dosing: Single-dose treatment may be insufficient due to limited ovicidal activity 1

  2. Improper administration: Taking ivermectin without food reduces bioavailability and efficacy 1

  3. Neglecting contact treatment: Failing to treat sexual, close personal, or household contacts can lead to reinfection 1

  4. Inadequate environmental decontamination: Not properly handling bedding and clothing can result in reinfestation 1

  5. Insufficient treatment for crusted scabies: Single-dose treatment frequently fails in crusted scabies cases, requiring the more intensive regimen outlined above 1

While ivermectin has shown activity against other parasites including Ascaris lumbricoides and Entamoeba coli 2, and has been reported effective against combined intestinal protozoal infections like giardiasis and cryptosporidiosis in animal models 3, the established human dosing is primarily documented for ectoparasites like scabies.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.